Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K was filed by Viewbix Inc. (noted as Quantum X Labs Inc. in metadata) on June 20, 2024, reporting events occurring on June 18, 2024. The registrant is incorporated in Delaware and headquartered in Ramat Gan, Israel. The filing discloses the entry into a material definitive agreement and the creation of a direct financial obligation.

Key Financial Metrics and Obligations

  • Credit Facility Amount: $1,000,000 new facility.
  • Prior Debt Included: $530,657 of outstanding debt rolled into the facility.
  • Total Loan Amount: $1,530,657.
  • Interest Rate: 12% per annum.
  • Interest Payment Method: Payable in common stock and warrants rather than cash. Accrued interest on prior debt is valued at $183,679.
  • Conversion Price: $0.25 per share for interest and principal conversion.
  • Drawdown Schedule:
    • $350,000 drawn immediately.
    • $150,000 upon filing of the Facility Registration Statement.
    • $500,000 upon effectiveness of the Uplist (uplisting to a national exchange).

Material Changes and Transaction Details

The primary material change is the restructuring of debt and the issuance of equity-linked securities. Upon the effectiveness of the Uplist, $662,957 of the Loan Amount will automatically convert into common stock and warrants (Conversion Units). The remaining unconverted portion may be converted at the lenders' election or repaid at the end of the term.

Term: The facility expires 12 months following the effectiveness of the Uplist.

Lead Lender Compensation: L.I.A. Pure Capital Ltd. received a commission consisting of 200,000 shares, a warrant for 200,000 shares (exercise price $0.25), and a separate warrant for 2,500,000 shares (exercise price $1.00).

Guidance, Outlook, and Risks

Contingencies: The repayment and conversion mechanics are heavily contingent on the "Uplist" (uplisting of shares to a national securities exchange). The filing explicitly states that this uplisting is subject to conditions and may not occur.

Risks:

  • Dilution: Significant issuance of shares and warrants is required to service interest and principal, potentially diluting existing shareholders.
  • Uplisting Failure: If the uplisting does not occur, the conversion triggers may not activate as planned, and the term of the facility remains undefined relative to a specific date.
  • Unregistered Securities: The securities described have not been registered under the Securities Act of 1933 and cannot be sold in the U.S. absent registration or exemption.

Investor Verification Checklist

  • Verify the current status of the "Uplist" (uplisting to a national exchange) and whether conditions have been met.
  • Confirm the exact number of shares and warrants issued to date versus those pending upon the Uplist.
  • Review the "Facility Registration Statement" to ensure the resale of shares by lenders is properly registered.
  • Assess the dilution impact of the 734,715 shares issued for interest and the potential conversion of $662,957 of principal.
  • Check for any subsequent filings regarding the drawdown of the remaining $1,150,000 of the facility.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.